Related references
Note: Only part of the references are listed.Can rodent models elucidate the pathomechanisms of genetic epilepsy?
Motohiro Okada
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Reduced expression of dopamine D2 receptors on astrocytes in R6/1 HD mice and HD post-mortem tissue
Kate L. Harris et al.
NEUROSCIENCE LETTERS (2022)
Impact of 5-HT7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain
Kouji Fukuyama et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis
Nicolas A. Nunez et al.
JOURNAL OF AFFECTIVE DISORDERS (2022)
Astroglial Connexin43 as a Potential Target for a Mood Stabiliser
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Crosstalk of hypothalamic chemerin, histamine, and AMPK in diet-and olanzapine-induced obesity in rats
Doaa M. Samy et al.
LIFE SCIENCES (2021)
Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Integration of Nutrient Sensing in Fish Hypothalamus
Jose L. Soengas
FRONTIERS IN NEUROSCIENCE (2021)
Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Ruri Okubo et al.
FRONTIERS IN PSYCHIATRY (2021)
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli et al.
PHARMACEUTICALS (2021)
Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion
Kouji Fukuyama et al.
PHARMACEUTICALS (2021)
Brivaracetam prevents astroglial L-glutamate release associated with hemichannel through modulation of synaptic vesicle protein
Motohiro Okada et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Effects of Atypical Antipsychotics, Clozapine, Quetiapine and Brexpiprazole on Astroglial Transmission Associated with Connexin43
Kouji Fukuyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43
Takashi Shiroyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Obesity medications in development
Candida J. Rebello et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
A positron emission tomography occupancy study of brexpiprazole at dopamine D-2 and D-3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
Ragy R. Girgis et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Activation of Astroglial Connexin Is Involved in Concentration-Dependent Double-Edged Sword Clinical Action of Clozapine
Kouji Fukuyama et al.
CELLS (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Effects of Carbamazepine, Lacosamide and Zonisamide on Gliotransmitter Release Associated with Activated Astroglial Hemichannels
Kouji Fukuyama et al.
PHARMACEUTICALS (2020)
A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Age-Dependent and Sleep/Seizure-Induced Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy
Kouji Fukuyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Perspective
Edward M. Wojtys
SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH (2019)
Lurasidone inhibits NMDA receptor antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-HT7 receptor blockade
Motohiro Okada et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor
Kouji Fukuyama et al.
BIOMOLECULES (2019)
The 5-HT1A receptor: Signaling to behavior
Paul R. Albert et al.
BIOCHIMIE (2019)
Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT1A Receptor with 5-HT3 Receptor Inhibition in Rats
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus
Motohiro Okada et al.
PHARMACEUTICALS (2019)
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
C. Hiemke et al.
PHARMACOPSYCHIATRY (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
5-HT1A receptor-mediated activation of neuroendocrine responses and multiple protein kinase pathways in the peripubertal rat hypothalamus
Maureen L. Petrunich-Rutherford et al.
NEUROPHARMACOLOGY (2018)
The antipsychotic agent clozapine induces autophagy via the AMPK-ULK1-Beclin1 signaling pathway in the rat frontal cortex
Se Hyun Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians
Georgios Schoretsanitis et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites
Kouji Fukuyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Serotonin receptors in depression and anxiety: Insights from animal studies
Elzbieta Zmudzka et al.
LIFE SCIENCES (2018)
A meta-analysis of factors associated with quality of life in first episode psychosis
Philip Watson et al.
SCHIZOPHRENIA RESEARCH (2018)
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism
Stefano Aringhieri et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Yang Zhao et al.
MOLECULAR CANCER (2017)
Involvement of presynaptic 5-HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats
Cedric Mombereau et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
Mechanism of action of brexpiprazole: comparison with aripiprazole
Stephen M. Stahl
CNS SPECTRUMS (2016)
Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study
Maurizio Fava et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Antidepressants Impact Connexin 43 Channel Functions in Astrocytes
Tiffany Jeanson et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway
Yan-Juan Wang et al.
ONCOTARGET (2016)
AMPK Suppresses Connexin43 Expression in the Bladder and Ameliorates Voiding Dysfunction in Cyclophosphamide-induced Mouse Cystitis
Xiling Zhang et al.
SCIENTIFIC REPORTS (2016)
Regulation and function of AMPK in physiology and diseases
Sang-Min Jeon
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors
K. W. Andressen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
Leslie Citrome et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study
Michael E. Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder: A Phase 3, Randomized, Placebo-Controlled Study in Patients With Inadequate Response to Antidepressants
Michael E. Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Trazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes
Simona Daniele et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Regulation of dopamine D2 receptor-mediated extracellular signal-regulated kinase signaling and spine formation by GABAA receptors in hippocampal neurons
Dong-Hoon Yoona et al.
NEUROSCIENCE LETTERS (2015)
Attenuated Levels of Hippocampal Connexin 43 and its Phosphorylation Correlate with Antidepressant- and Anxiolytic-Like Activities in Mice
Gael Quesseveur et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
Leslie Citrome et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Molecular targets on mast cells and basophils for novel therapies
Ilkka T. Harvima et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
A Head-to-Head Comparison of Aripiprazole and Risperidone for Safety and Treating Autistic Disorders, a Randomized Double Blind Clinical Trial
Ahmad Ghanizadeh et al.
CHILD PSYCHIATRY & HUMAN DEVELOPMENT (2014)
ONO-2506 inhibits spikewave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation
Satoshi Yamamura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Serotonin and the 5-HT7 receptor: The link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors
Bernhard Svejda et al.
CANCER SCIENCE (2013)
Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders
Francisco López-Muñoz et al.
Frontiers in Psychiatry (2013)
Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
Shunske Tanahashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Gap Junction Dysfunction in the Prefrontal Cortex Induces Depressive-Like Behaviors in Rats
Jian-Dong Sun et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
Tadashi Ishibashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Inhibitory crosstalk between ERK and AMPK in the growth and proliferation of cardiac fibroblasts
Jianhai Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats
S. Hossein Fatemi et al.
SCHIZOPHRENIA RESEARCH (2008)
Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase
Sangwon F. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
PB Hedlund et al.
BIOLOGICAL PSYCHIATRY (2005)
Involvement of the βγ subunits of G proteins in the cAMP response induced by stimulation of the histamine H1 receptor
T Maruko et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration
BH Yang et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2004)
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile
AW Schmidt et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Serotonin 2A receptor-like immunoreactivity is detected in astrocytes but not in oligodendrocytes of rat spinal cord
M Maxishima et al.
BRAIN RESEARCH (2001)